Femasys Inc (FEMY): Total Liabilities

Annual figures by period end, from SEC filings.

$14.85M
As of 2025-12-31
$8.26M
As of 2026-06-30
+107.9%
3-year compound annual growth
+29.5%
5-year compound annual growth
2020-12-31: $4.08M2021-12-31: $2.24M2022-12-31: $1.65M2023-12-31: $9.40M2024-12-31: $10.14M2025-12-31: $14.85M$14.85M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$14.85M+46.5%2026-03-31, Balance as of period end
2024-12-31$10.14M+7.8%2026-03-31, Balance as of period end
2023-12-31$9.40M+468.8%2025-03-27, Balance as of period end
2022-12-31$1.65M-26.3%2024-03-28, Balance as of period end
2021-12-31$2.24M-45.0%2023-07-24, Balance as of period end
2020-12-31$4.08Mn/a2022-03-24, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Femasys Inc (FEMY)2025-12-31$14.85M+46.5%
QHSLab, Inc. (USAQ)2025-12-31$546.1K-77.3%
Vycor Medical Inc (VYCO)2025-12-31$4.92M+4.9%
OSR Health, Inc. (OSRH)2025-12-31$44.20M+38.0%
EBR Systems, Inc. (NONE.)2025-12-31$71.64M+45.6%
Nuo Therapeutics, Inc. (AURX)2025-12-31$2.80M+314.7%
Tenon Medical, Inc. (TNON)2025-12-31$5.72M+47.7%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$6.65M+22.4%
SeaStar Medical Holding Corp (ICU)2025-12-31$3.74M-45.3%

Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗